₹105
(Inclusive of all Taxes)
₹15.8 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
உற்பத்தியாளர்/சந்தைப்படுத்துபவர் :
ஐபிகா ஆய்வகங்கள் லிமிடெட்
உட்கொள்ளும் வகை :
வாய்வழி
திரும்பப் பெறும் கொள்கை :
திரும்பப் பெற முடியாது
முடிவடையும் தேதி அல்லது அதற்குப் பிறகு :
Jan-27
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Arbitel-CT 40/6.25 Tablet:
Co-administration of Aliskiren with Arbitel-CT 40/6.25 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Arbitel-CT 40/6.25 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Co-administration of Aliskiren with Arbitel-CT 40/6.25 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Arbitel-CT 40/6.25 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Critical
How does the drug interact with Arbitel-CT 40/6.25 Tablet:
Co-administration of Arbitel-CT 40/6.25 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Arbitel-CT 40/6.25 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Co-administration of Arbitel-CT 40/6.25 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Arbitel-CT 40/6.25 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Arbitel-CT 40/6.25 Tablet:
Taking lisinopril with Arbitel-CT 40/6.25 Tablet may increase the levels of potassium in blood.
How to manage the interaction:
Although there is a possible interaction, Arbitel-CT 40/6.25 Tablet can be taken with lisinopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications.
Taking lisinopril with Arbitel-CT 40/6.25 Tablet may increase the levels of potassium in blood.
How to manage the interaction:
Although there is a possible interaction, Arbitel-CT 40/6.25 Tablet can be taken with lisinopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications.
Severe
How does the drug interact with Arbitel-CT 40/6.25 Tablet:
Taking quinapril with Arbitel-CT 40/6.25 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Arbitel-CT 40/6.25 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking quinapril with Arbitel-CT 40/6.25 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Arbitel-CT 40/6.25 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
TelmisartanEluxadoline
Severe
How does the drug interact with Arbitel-CT 40/6.25 Tablet:
Co-administration of Arbitel-CT 40/6.25 Tablet increases levels of eluxadoline by increasing metabolism.
How to manage the interaction:
Taking Arbitel-CT 40/6.25 Tablet with Eluxadoline together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without consulting a doctor.
Co-administration of Arbitel-CT 40/6.25 Tablet increases levels of eluxadoline by increasing metabolism.
How to manage the interaction:
Taking Arbitel-CT 40/6.25 Tablet with Eluxadoline together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Arbitel-CT 40/6.25 Tablet:
Coadministration of enalapril with Arbitel-CT 40/6.25 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Arbitel-CT 40/6.25 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of enalapril with Arbitel-CT 40/6.25 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Arbitel-CT 40/6.25 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
TelmisartanPotassium acetate
Severe
How does the drug interact with Arbitel-CT 40/6.25 Tablet:
Co-administration of Potassium acetate can make Arbitel-CT 40/6.25 Tablet more likely to cause high levels of potassium in the blood.
How to manage the interaction:
Although taking Potassium acetate and Arbitel-CT 40/6.25 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Co-administration of Potassium acetate can make Arbitel-CT 40/6.25 Tablet more likely to cause high levels of potassium in the blood.
How to manage the interaction:
Although taking Potassium acetate and Arbitel-CT 40/6.25 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Arbitel-CT 40/6.25 Tablet:
Taking perindopril with Arbitel-CT 40/6.25 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Arbitel-CT 40/6.25 Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking perindopril with Arbitel-CT 40/6.25 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Arbitel-CT 40/6.25 Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Arbitel-CT 40/6.25 Tablet:
Co-administration of Arbitel-CT 40/6.25 Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Arbitel-CT 40/6.25 Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
Co-administration of Arbitel-CT 40/6.25 Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Arbitel-CT 40/6.25 Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
TelmisartanPotassium citrate
Severe
How does the drug interact with Arbitel-CT 40/6.25 Tablet:
Taking Potassium citrate with Arbitel-CT 40/6.25 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Arbitel-CT 40/6.25 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Taking Potassium citrate with Arbitel-CT 40/6.25 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Arbitel-CT 40/6.25 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Drug-Food Interactions
CHLORTHALIDONE-6.25MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Drug-Food Interactions
Login/Sign Up
CHLORTHALIDONE-6.25MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Common Foods to Avoid:
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Arbitel-CT 40/6.25 Tablet along with potassium-containing salt substitutes or over-the-counter potassium supplements it may lead to high potassium levels in blood. Avoid high potassium rich food while taking Arbitel-CT 40/6.25 Tablet as it can possibly result in an interaction. However, consult a doctor if you experience weakness, irregular heartbeat, confusion and feelings of heaviness in the legs.
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Arbitel-CT 40/6.25 Tablet along with potassium-containing salt substitutes or over-the-counter potassium supplements it may lead to high potassium levels in blood. Avoid high potassium rich food while taking Arbitel-CT 40/6.25 Tablet as it can possibly result in an interaction. However, consult a doctor if you experience weakness, irregular heartbeat, confusion and feelings of heaviness in the legs.
Product Substitutes
மது
பாதுகாப்பற்றது
நீங்கள் மது அருந்துவதைத் தவிர்க்க பரிந்துரைக்கப்படுகிறது மற்றும் Arbitel-CT 40/6.25 Tablet 10's மயக்கம், தலைச்சுற்றல் மற்றும் கல்லீரல் பாதிப்பு போன்ற விரும்பத்தகாத பக்க விளைவுகளைத் தவிர்க்கவும்.
கர்ப்பம்
பாதுகாப்பற்றது
Arbitel-CT 40/6.25 Tablet 10's கர்ப்ப காலத்தில் பரிந்துரைக்கப்படவில்லை, ஏனெனில் இது ஒரு வகை D கர்ப்ப மருந்து. இந்த மருந்து கருவிற்கு சேதத்தை ஏற்படுத்தலாம் மற்றும் பிறக்காத குழந்தையை (கரு) பாதிக்கலாம்.
தாய்ப்பால்
பாதுகாப்பற்றது
Arbitel-CT 40/6.25 Tablet 10's தாய்ப்பாலில் கலப்பது தெரிந்ததே, ஆனால் குழந்தையின் மீதான அதன் விளைவு தெரியவில்லை. எனவே, தாய்ப்பால் கொடுப்பதற்கு முன், இதைப் பற்றி உங்கள் மருத்துவரிடம் தெரிவிக்கவும். Arbitel-CT 40/6.25 Tablet 10's பயன்படுத்துவதற்கு நீங்கள் தாய்ப்பாலை நிறுத்த வேண்டும், அல்லது Arbitel-CT 40/6.25 Tablet 10's எடுத்துக்கொள்வதை நிறுத்த வேண்டும்.
ஓட்டுதல்
பாதுகாப்பற்றது
எச்சரிக்கையுடன் ஓட்டவும், Arbitel-CT 40/6.25 Tablet 10's பொதுவாக மயக்கத்தை ஏற்படுத்துகிறது மற்றும் ஓட்டும் திறனை பாதிக்கிறது.
கல்லீரல்
எச்சரிக்கை
Arbitel-CT 40/6.25 Tablet 10's எச்சரிக்கையுடன் எடுத்துக்கொள்ள வேண்டும், குறிப்பாக உங்களுக்கு கல்லீரல் நோய் இருந்திருந்தால். உங்கள் மருத்துவர் உங்கள் மருத்துவ நிலை மற்றும் சிகிச்சைக்கான உங்கள் எதிர்வினையைப் பொறுத்து மருந்தளவை மாற்றுவார்.
சிறுநீரகம்
பாதுகாப்பற்றது
நாள்பட்ட சிறுநீரக நோய் (கடுமையான சிறுநீரகக் குறைபாடு) உள்ள நோயாளிகளுக்கு பரிந்துரைக்கப்படவில்லை. கடுமையான சிறுநீரகக் குறைபாடு உள்ள நோயாளிகளுக்கு பாதுகாப்பு மற்றும் செயல்திறன் நிறுவப்படவில்லை.
குழந்தைகள்
எச்சரிக்கை
Arbitel-CT 40/6.25 Tablet 10's இன் செயல்திறன் மற்றும் பாதுகாப்பு குழந்தைகளில் நிறுவப்படவில்லை. பரிந்துரைக்கப்பட்டால், அது கண்டிப்பாக மருத்துவ மேற்பார்வையின் கீழ் இருக்க வேண்டும், மேலும் நன்மைகள் தீங்குகளை விட அதிகமாக இருந்தால் மட்டுமே.
Have a query?
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
